Monarch Partners Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Monarch Partners Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-266,364	Closed	-$5.09M	–	160
2022 Q3	$5.09M	Buy	266,364 +114,965	+76%	+$2.09M	1.53%	6
2022 Q2	$2.31M	Buy	151,399 +20,755	+16%	+$307K	0.65%	76
2022 Q1	$2.66M	Buy	130,644 +18,525	+17%	+$377K	0.59%	74
2021 Q4	$3.27M	Buy	112,119 +9,488	+9%	+$272K	0.67%	61
2021 Q3	$2.21M	Buy	102,631 +14,236	+16%	+$344K	0.32%	106
2021 Q2	$2.27M	Buy	+88,395	New	+$1.89M	0.33%	100

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Monarch Partners Asset Management's CDMO Position: Q4 2022 in Review

Monarch Partners Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2022, closing a stake of 266,364 shares — an estimated $5.09M sold.

Monarch Partners Asset Management first reported a position in CDMO in Q2 2021 and held it in 6 quarters. The position peaked at $5.09M in Q3 2022. 168 funds tracked by Wall St. Rank hold CDMO as of Q4 2022.

Monarch Partners Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Monarch Partners Asset Management sold 266,364 Avid Bioservices, Inc. Common Stock shares in Q4 2022, an estimated $5.09M.
Monarch Partners Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Monarch Partners Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $5.09M in Q3 2022.
168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2022.

Based on Monarch Partners Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.